{"id":"benzomethamine","rwe":[],"tags":[{"label":"benzomethamine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["benzomethamine"],"offLabel":[],"synonyms":["benzomethamine"],"timeline":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"benzomethamine","explanation":"Imagine benzomethamine as a key that fits into a lock on a cell's surface. When it binds to this lock, it triggers a series of events that ultimately lead to a desired outcome, such as reducing inflammation or blocking a harmful signal. This process is complex and involves many molecular interactions, but essentially, benzomethamine helps to restore balance to the body's natural processes.","oneSentence":"Benzomethamine is thought to work by interacting with a specific molecular target to produce a therapeutic effect.","technicalDetail":"Benzomethamine is a small molecule that binds to a specific receptor or enzyme, altering its activity and leading to a cascade of downstream effects that ultimately produce its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/325","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=benzomethamine","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T08:59:04.181933","biosimilars":[],"competitors":[],"genericName":"benzomethamine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"J12SSB9864","UMLSCUI":"C0053226","PUBCHEM_CID":"10520","MESH_SUPPLEMENTAL_RECORD_UI":"C006705"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":7,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"benzomethamine","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Benzomethamine is a small molecule drug in the benzomethamine class, but specific details about its development, commercial status, and approved indications are not available. As a result, there is limited information on its target, pharmacokinetics, and safety profile. Further research is needed to understand its mechanism of action and potential therapeutic applications. The current owner of benzomethamine is not publicly disclosed. Due to the lack of available information, its commercial status and off-patent status remain unknown.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}